.svg)
Prenatal genomic testing for faster, clearer answers
When fetal findings raise concern, every week matters. GeneDx gives you flexible access to CMA, exome, and genome testing backed by deep prenatal expertise, fast turnaround times, and the power of GeneDx Infinity™.
Clarity in the moments that matter most
Every report we create is powered by GeneDx Infinity™, the largest rare disease and prenatal exome dataset, giving your patients access to insights informed by decades of genomic expertise.
- ~1M exomes & genomes sequenced
- 5K+ prenatal exomes sequenced
- 2.5M+ tests
- 8M+ phenotypes
Testing options for every step toward an answer
From CMA to exome and genome, GeneDx offers a comprehensive prenatal testing portfolio so you can choose the approach that fits your patient's clinical presentation, including a range of fetal anomalies and ultrasound findings. Our suite of prenatal tests helps you uncover answers with precision and speed without needing to work with multiple labs or collect multiple samples.
CMA
Consider when: Abnormal serum screening, non-diagnostic karyotype, or fetal ultrasound anomalies suggest a deletion or duplication syndrome.
Turnaround time: ~2 weeks
Prenatal testing pathways
Start with CMA. Add the power of exome.
Pair CMA with ExomeDx™ Prenatal to evaluate chromosomal and sequence-level causes of fetal anomalies.
Available: Concurrent or Reflex
TAT: 2 weeks
Start with CMA. Expand to genome when needed.
Pair CMA with GenomeDx™ Prenatal for a streamlined path to broader genomic analysis.
Available: Concurrent or Reflex
TAT: 2 weeks
Start with exome. Keep the path to genome open.
Begin with ExomeDx™ Prenatal and automatically reflex to GenomeDx™ Prenatal when exome does not fully explain the fetal findings.
Available: Reflex
TAT: As soon as 2 weeks
*Incremental diagnostic yield
*Incremental diagnostic yield
Specimen requirements
GeneDx accepts a range of prenatal specimen types, including amniotic fluid, cultured amniocytes, cultured chorionic villi (CVS), products of conception (POC), and extracted DNA. A maternal blood or buccal sample is required for maternal cell contamination (MCC) studies.
Make trio testing easier with flexible parental samples. Maternal and paternal blood or buccal samples can be submitted for exome or genome trio testing, making parental sample collection more convenient.
More accessible genomic testing starts here
GeneDx accepts commercial insurance plans, Medicaid, Medicare, and TRICARE. Our dedicated billing team helps navigate coverage, with additional patient access options available for eligible families.
When to consider prenatal exome sequencing
When fetal anomalies raise concern, sequential testing can consume valuable time. For appropriate patients, earlier exome testing can provide a more comprehensive approach to finding an answer.
See prenatal genomics in practice
Explore real cases and clinical education designed to help you apply genomic testing in prenatal care.
When CMA doesn’t provide the answer
See how prenatal exome sequencing helped uncover a diagnosis after chromosomal microarray testing was non-diagnostic.
From fetal findings to a genomic answer
Explore a real prenatal case and see how broader genomic testing helped provide answers during pregnancy.
Counseling considerations in the genomic era of prenatal testing
Explore key counseling considerations in prenatal genomic sequencing, including fetal and parental findings, clinical implications, transition of care, and multidisciplinary coordination.
Give families clearer answers, faster.
From choosing the right test to navigating results, GeneDx is here to support you and your patients at every step.